Privium Fund Management B.V. Merck & Co., Inc. Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
A detailed history of Privium Fund Management B.V. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 72,611 shares of MRK stock, worth $6.76 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
72,611
Previous 60,111
20.79%
Holding current value
$6.76 Million
Previous $6.83 Million
5.82%
% of portfolio
1.66%
Previous 1.7%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,972Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.3 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.52 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.7 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $236B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...